摘要
内在或获得性化疗耐药是癌症患者成功治疗的主要障碍。多药耐药机制涉及:亲水性药物摄取减少,外排能量依赖性增加,氧化还原状态改变,凋亡途径改变,肿瘤微环境改变等。近年来,开发了几种纳米粒子来克服这些障碍,并且改善药物在病理部位的积聚和释放。在这篇综述中,我们描述了涉及多重耐药性的主要机制和已经提出的针对这一现象的特定方面的纳米载体。
关键词: 癌症,化疗耐药机制,药物递送,miRNA / siRNA递送,纳米颗粒,米托蒽醌,柔红霉素。
Current Medicinal Chemistry
Title:Drug Delivery Nanoparticles in Treating Chemoresistant Tumor Cells
Volume: 24 Issue: 42
关键词: 癌症,化疗耐药机制,药物递送,miRNA / siRNA递送,纳米颗粒,米托蒽醌,柔红霉素。
摘要: Intrinsic or acquired chemoresistance represents the main obstacle to the successful treatment of cancer patients. Several mechanisms are involved in multidrug resistance: decreased uptake of hydrophilic drugs, increase of energy dependent efflux, alteration of the redox state, alteration of apoptotic pathways, and modification of the tumor microenvironment. In recent years, several types of nanoparticles have been developed to overcome these obstacles and improve the accumulation and release of drugs at the pathological site. In this review, we describe the main mechanisms involved in multidrug resistance and the nanovehicles which have been proposed to target specific aspects of this phenomenon.
Export Options
About this article
Cite this article as:
Drug Delivery Nanoparticles in Treating Chemoresistant Tumor Cells, Current Medicinal Chemistry 2017; 24 (42) . https://dx.doi.org/10.2174/0929867323666161205122225
DOI https://dx.doi.org/10.2174/0929867323666161205122225 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immune Checkpoint Inhibitors and Neurotoxicity
Current Neuropharmacology Lupus Nephritis: A Treatment Update
Current Clinical Pharmacology Fc-fusion Proteins in Therapy: An Updated View
Current Medicinal Chemistry A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
Current Cancer Drug Targets Unlocking the Molecular Mechanisms of DNA Repair and Platinum Drug Resistance in Cancer Chemotherapy
Current Drug Therapy Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers
Recent Patents on Anti-Infective Drug Discovery Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery Copper Transport Systems are Involved in Multidrug Resistance and Drug Transport
Current Medicinal Chemistry Aquaporin Water Channels in Central Nervous System
Current Neurovascular Research Retinoic Acid Metabolism and Mechanism of Action: A Review
Current Drug Metabolism Current Targets for Anticancer Drug Discovery
Current Drug Targets Application of Efficient Nanoparticles for Early Diagnosis and Treatment of Cancer
Current Drug Metabolism Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Current Nanoscience ras Genes and Human Cancer: Different Implications and Different Roles
Current Genomics E2F1-Mediated Apoptosis as a Target of Cancer Therapy
Current Molecular Pharmacology The Role of Survivin for Radiation Oncology: Moving Beyond Apoptosis Inhibition
Current Medicinal Chemistry Experimental Onco-Immunology Revisited
Current Cancer Therapy Reviews Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Current Pharmaceutical Design Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions
Current Medicinal Chemistry Organic Nanotheranostics for Photoacoustic Imaging-Guided Phototherapy
Current Medicinal Chemistry